StamlerJVaccaroONeatonJD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care1993; 16: 434–444.
2.
GaedePLund-AndersenHParvingHH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med2008; 358: 580–591.
3.
DonahoeSMStewartGCMcCabeCH, et al. Diabetes and mortality following acute coronary syndromes. JAMA2007; 298: 765–775.
4.
GencerBRigamontiFNanchenD, et al. Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: a prospective cohort study. Eur Heart J: Acute Cardiovasc Care2020; 9(6).
5.
BjarnasonTAHafthorssonSOKristinsdottirLB, et alThe prognostic effect of known and newly detected type 2 diabetes in patients with acute coronary syndrome. Eur Heart J: Acute Cardiovasc Care2020; 9(6).
6.
HermanidesRSKennedyMWKedhiE, et alImpact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a ‘real world’ prospective registry of the Zwolle Myocardial Infarction Study Group. Eur Heart J: Acute Cardiovasc Care2020; 9(6).
7.
MohrGHSøndergaardKBPallisgaardJL, et al. Survival of patients with and without diabetes following out-of-hospital cardiac arrest: a nationwide Danish study. Eur Heart J: Acute Cardiovasc Care2020; 9(6).
8.
NorhammarATenerzANilssonG.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet2002; 359: 2140–2144.
9.
BartnikMRydenLFerrariR, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on Diabetes and the Heart. Eur Heart J2004; 25: 1880–1890.
10.
HuDPanC-YYuJ-M; China Heart Survey Group. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J2006; 27: 2573–2579.
11.
CosentinoFGrantPJAboyansV, et al.; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J2020; 41: 255–323.